Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer
<p>Caris AI Insights for pancreatic cancer is proprietary, only available to Caris Life Sciences customers and not achievable through small panels IRVING, Texas, Aug. 27, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the publication of a...</p>
Read original article ↗
Related Articles
Delivering Vera: NVIDIA’s First CPU Built for Agents Is Shipping Now
NVIDIA Vice President of Hyperscale and HPC Ian Buck hand-delivers Vera CPU systems across the AI ecosystem as Vera begi
Adobe is adding more AI to Photoshop
Adobe is rolling out an AI-heavy update for Photoshop that includes a new "optional" interface dedicated to its AI tools
Sweepstakes celebrates generations of memorable moments with Whirlpool, KitchenAid, Maytag, JennAir, Amana and InSinkEra
OpenAI's first AI accelerator fails to beat Nvidia's Blackwell in terms of raw performance, but it can offer very good p